@NEJMres360 Journal Club: Hosted by University of Vermont Internal Medicine Residency Program on C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations

Q&A begins
Authors
    • Family Medicine
    • Motivational Interviewing
    • health behavior change
    • clincial trials
    • point of care testing
    • Common infections

    Chris Butler, National Institute of Health Research Senior Investigator and Fellow of the Academy of Medical Sciences,  is professor of primary care at the University of Oxford’s Nuffield Department of Primary Care Health Sciences and professorial fellow at Trinity College. He is the Clinical Director of the University of Oxford Primary Care Clinical Trials Unit, and of the NIHR Community Healthcare Medical Technology and In-Vitro Diagnostics Co-operative. 

    His main research interests are in common infections (especially the appropriate use of antibiotics and antibiotic resistance), and health care communication and behaviour change. He has led or helped lead >20 randomised clinical trials in primary care, helped win >£240M in research and research infrastructure funding, and has >350 publications. He is a salaried General Medical Practitioner for the Cwm Taf University Health Board, practicing in Mountain Ash in South Wales. He has expertise in clinical trials, cohort studies, qualitative research and analysis of routinely collected data. He was the co-chief investigator of the General Practitioner (GP) use of aC-Reactive Protein (CRP) Point of Care Test (POCT) to help target antibiotic prescribing to patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) who are most likely to benefit (The PACE Study).